<0> CovidienRhonda Luniak, 303-305-2263Vice PresidentR&MS CommunicationsorBruce Farmer, 508-452-4372Vice PresidentPublic RelationsorColeman Lannum, CFA, 508-452-4343Vice PresidentInvestor ...

Leading health care products company, Covidien plc. (COV) recently won the U.S. Food and Drug Administration (:FDA) 510(k) approval as well as the European Economic Area (EEA) CE Mark clearance for ...

International healthcare products major, Covidien plc ( COV) has started labeling its Nellcor pulse oximeters to promote the usefulness of the product line for Critical Congenitial Heart Disease (CCHD ...

Covidien has announced it has received FDA clearance to market the Covidien Nellcor Bedside SpO2 Patient Monitoring System, according to a news release. The Nellcor Bedside SpO2 system includes the ...

Medtronic plc MDT recently announced favourable outcome of an independent prospective observational study, which was published online in the Journal of Perinatology. This study compared the efficacy ...

The updated Nellcor Bedside SpO2 patient monitoring system will be marketed to hospitals to monitor blood oxygen levels and pulse rates in adult, pediatric and neonatal patients.

Covidien Receives FDA 510(k) Clearance for Nellcor™ Pulse Oximetry Motion Claims Nellcor pulse oximeters only FDA 510(k)-cleared oximeters compliant with ISO 80601-2-61 BOULDER, Colo.--(BUSINESS WIRE) ...

Covidien has announced it has received FDA clearance and CE Mark approval for its bedside respiratory patient monitoring system, according to a news release. The company says the Nellcor system is ...